Item Details

T-019 / T-019-1MLUpdated item number format

(-)-11-nor-9-Carboxy-Δ9-THC (Suitable for use with immunoassay)
1.0 mg/mL in Methanol | Certified Reference Material

11-Nor-9-carboxy-Δ9-tetrahydrocannabinol (THC acid or THC-COOH), the main secondary metabolite of THC detected in urine and blood, is a key biomarker in clinical toxicology and urine drug testing. Accurate quantification supports forensic cannabis investigations. LC-MS/MS and GC-MS methods require accurate CRMs to ensure reliable results.

Concentration
:    1.0 mg/mL
Solvent
:    Methanol
Unit Size
:    1 mL/ampoule
CAS Number
:    56354-06-4
Chemical Formula:
:    C21H28O4
Molecular Weight:
:    344.44
Certificate of Analysis
Need a different COA
US List Price
$176.00 EA
**All prices shown are for sales within US and Canada.**
Quantity
**Eligible Discounts Applied at Checkout**
Product Image
T-003 / T-003-1ML (-)-Δ9-THC-D3, 100 μg/mL $94.60
T-004 / T-004-1ML (±)-11-nor-9-Carboxy-Δ9-THC-D3, 100 μg/mL $49.30
T-005 / T-005-1ML (-)-Δ9-THC, 1.0 mg/mL $39.80
T-006 / T-006-1ML (±)-11-nor-9-Carboxy-Δ9-THC (Racemic mixture - not to be used for immunoassay), 100 μg/mL $40.90
T-007 / T-007-1ML (±)-11-nor-9-Carboxy-Δ9-THC-D9, 100 μg/mL $57.50
T-008 / T-008-1ML (±)-11-nor-9-Carboxy-Δ9-THC-D3, 1.0 mg/mL $278.00
T-010 / T-010-1ML (±)-11-nor-9-Carboxy-Δ9-THC (Racemic mixture - not to be used for immunoassay), 1.0 mg/mL $328.00
T-011 / T-011-1ML (-)-Δ9-THC-D3, 1.0 mg/mL $716.00
T-018 / T-018-1ML (-)-11-nor-9-Carboxy-Δ9-THC (Suitable for use with immunoassay), 100 μg/mL $46.40
T-038 / T-038-1ML (+)-11-nor-9-Carboxy-Δ9- THC glucuronide, 100 μg/mL $328.00
T-080 / T-080-1ML (±)-cis-11-Nor-9-carboxy-Δ9-THC-D3 glucuronide, 100 μg/mL $408.00

Regulatory Control

▶  Canada Test Kit Registration # 61-1548 - no Health Canada import authorization required
Read more about ordering regulated substances

Recommended Storage Condition

Freeze

UN Number, Class, PG

1230, 3, II

Safety Data Sheet

View SDS

HS Code

3822.90.0000
A Validated Chiral HPLC Method for Resolution of ?8 and ?9 – Tetrahydrocannabinol Enantiomers | Tamara Tarbox, Isil Dilek PhD, Uma Sreenivasan PhD, Kenan Yaser, Cerilliant, 2009
Investigation of the Impurities in Dronabinol Samples by LCMS | Huahua Jian, Isil Dilek, Uma Sreenivasan, Kenan Yaser, Cerilliant, 2010
LC/MS (TOF) Analysis of Drugs and Their Glucuronide Metabolites on Titan™ C18 after Solid Phase Extraction (SPE) using Supel™-Select SCX, ß-Glucuronidase Enzyme Digestion | Sigma-Aldrich®, 2014
Proof of Concept for Automated SPE/HPLC/MS/MS Methods to Replace Traditional Immunoassay with MS Confirmation of Driving Under the Influence Samples | Robert M. Sears, Toxicology Technical Leader , Kenneth Lewis, CEO , and Kim Gamble, President, ITSP Solutions, INC., 2014
Using UHPLC/MS (TOF) for Detection of Drugs and Metabolites in Urine following Optimized Enzymatic Hydrolysis Conditions | Sigma-Aldrich®, 2015